Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Patients With Bone Metastasis”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Early research (Phase 1)Ended earlyNCT02429804
What this trial is testing

NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma
Stanford University 4
Testing effectiveness (Phase 2)Study completedNCT02099864
What this trial is testing

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
OHSU Knight Cancer Institute 36
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Not applicableLooking for participantsNCT01050504
What this trial is testing

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more
University of Washington 1,500
Not applicableLooking for participantsNCT06659926
What this trial is testing

The Radium-select Study

Who this might be right for
mCRPCMale Urogenital Diseases
The Netherlands Cancer Institute 60
Not applicableUnknownNCT05154474
What this trial is testing

Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy

Who this might be right for
Metastatic CancerCancer, BreastCancer Colon+12 more
Weprom 150
Testing effectiveness (Phase 2)Looking for participantsNCT07292168
What this trial is testing

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

Who this might be right for
Renal Cell Carcinoma MetastaticProstate Cancer MetastaticNon-small Cell Lung Cancer Metastatic+2 more
Kidney Cancer Research Bureau 58
Not applicableStudy completedNCT02398526
What this trial is testing

Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases

Who this might be right for
Castration-Resistant Prostatic Cancer
Bayer 363
Not applicableNo Longer AvailableNCT01516762
What this trial is testing

Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer
Testing effectiveness (Phase 2)Ended earlyNCT02215161
What this trial is testing

Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMetastatic Prostate Carcinoma in the Soft Tissue+3 more
University of California, San Francisco 14
Post-approval studies (Phase 4)Study completedNCT00434447
What this trial is testing

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Who this might be right for
Bone Neoplasms
Novartis Pharmaceuticals 73
Testing effectiveness (Phase 2)Ended earlyNCT02565901
What this trial is testing

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v7+1 more
University of Washington 28
Early research (Phase 1)Study completedNCT00958477
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Who this might be right for
Prostate CancerBone Metastases
Merck KGaA, Darmstadt, Germany 26
Testing effectiveness (Phase 2)Study completedNCT02598895
What this trial is testing

Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
University of Washington 14
Early research (Phase 1)Study completedNCT00005634
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00874211
What this trial is testing

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Who this might be right for
Breast CancerLung CancerMetastatic Cancer+4 more
SWOG Cancer Research Network 3,571
Early research (Phase 1)Study completedNCT02458716
What this trial is testing

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaMetastatic Prostatic AdenocarcinomaProstate Carcinoma Metastatic to the Bone
Rutgers, The State University of New Jersey 26
Testing effectiveness (Phase 2)Ended earlyNCT01994590
What this trial is testing

Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT03217747
What this trial is testing

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more
M.D. Anderson Cancer Center 173
Large-scale testing (Phase 3)Ended earlyNCT00127387
What this trial is testing

Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

Who this might be right for
Lung CancerProstate CancerNeoplasm Metastasis+1 more
The University of Texas Health Science Center at San Antonio 54
Load More Results